O

OMER

Omeros Corporation
HealthcareBiotechnology|NASDAQ Global Market|US

Price

$11.91

Market Cap

$857.47M

Beta

2.53

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)+97.78%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio
FCF Yield-13.55%
Debt / Equity0.00
Interest Coverage-127.9x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for OMER.

OMER — Omeros Corporation Stock Analysis | Tessera Alpha